Chromatographic evidence for pyrraline formation during protein glycation in vitro and in vivo.
Pyrraline (epsilon-2-(formyl-5-hydroxymethyl-pyrrol-1-yl)-L-norleucine) is an advanced Maillard reaction product formed from 3-deoxyglucosone in the non-enzymatic reaction between glucose and the epsilon-amino group of lysine residues on proteins. Although its presence in vivo as well as in in vitro incubations of proteins with sugars has been documented by immunochemical methods using polyclonal and monoclonal antibodies, its formation in proteins has recently been questioned by similar methodology. To clarify this issue, we investigated pyrraline formation in proteins following alkaline hydrolysis and quantitation by high-performance liquid chromatography on a C18 reverse-phase column. Time- and sugar concentration-dependent increase in pyrraline formation was noted in serum albumin incubated with either 100 mM glucose or 50 mM 3-deoxyglucosone. Formation of pyrraline from 3-deoxyglucosone was rapid at slightly acidic pH, confirming its synthetic pathway through this Maillard reaction intermediate. Low levels of pyrraline (< 10 pmol/mg protein) were also detected in a pool of human skin collagen by this method, but no age effect was apparent. Using a slightly different approach, pyrraline-like material was detected in human plasma proteins following enzyme digestion and analysis by high performance liquid chromatography. Plasma from diabetic patients showed a significant increase in pyrraline-like material compared to controls. The levels in diabetic and normal individuals were 21.6 +/- 9.56 and 12.8 +/- 5.6 pmol per mg protein, respectively (P = 0.005), reflecting thereby the elevated levels of the immediate precursor of pyrraline, 3-deoxyglucosone, in diabetic plasma.
Portero-Otin
M
M
Institute of Pathology, Case Western Reserve University, Cleveland, OH 44106.
Nagaraj
R H
RH
Monnier
V M
VM
D000818:Animals; D001798:Blood Proteins / Q000378:metabolism*; D002417:Cattle; D002851:Chromatography, High Pressure Liquid; D003847:Deoxyglucose / Q000031:analogs & derivatives / Q000378:metabolism; D003920:Diabetes Mellitus / Q000097:blood; D005947:Glucose / Q000378:metabolism; D006031:Glycosylation; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D009646:Norleucine / Q000031:analogs & derivatives* / Q000378:metabolism; D011758:Pyrroles / Q000378:metabolism*; D012710:Serum Albumin, Bovine / Q000378:metabolism
D001798:Blood Proteins; D011758:Pyrroles; D012710:Serum Albumin, Bovine; C059571:2-formyl-5-(hydroxymethyl)pyrrole-1-norleucine; D009646:Norleucine; D003847:Deoxyglucose; C016350:3-deoxyglucosone; D005947:Glucose